The A-share innovative drug concept continued to strengthen, with Sinopharm hitting the daily limit, and Haite Bio and Weikang Pharmaceutical rising by more than 10%. Yuandong Bio, Baili Tianheng, Rongchang Bio, and Bibet-U also rose.
2026-03-10
The A-share innovative drug concept continued to strengthen, with Sinopharm hitting the daily limit, and Haite Bio and Weikang Pharmaceutical rising by more than 10%. Yuandong Bio, Baili Tianheng, Rongchang Bio, and Bibet-U also rose.